M.D. Osman İLHAN

He graduated from Ankara University Faculty of Medicine in 1978. After earning his specialization in internal diseases at the same Faculty in 1982, he did his military service as a chief assistant at GATA Hematology Clinic. After his compulsory service duty was given at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for minor specialization.

He became associate professor of hematology in 1990. He worked in Genoa, Italy to increase his knowledge and experience on leukemia. He took part in the first blood stem cell transplant team in Turkey.

He went to the USA in 1996 and got M.D. At the Anderson Cancer Center, Prof. Dr. Martin Korbling and Prof.

He became a professor of hematology in 1996.

In 1999, he was elected regional president of the ESFH (European Society for Hemapheresis).

Hemapheresis Association Founding President in 2000, Dr. İlhan entered the management of the World Apheresis Association (WAA) in 2001. Again in October 2001, he became the President of the Turkish Hematology Association. Active in the European Union of Hematology (EHA), Dr. İlhan made a board of education within the body of ECAH (European Hematology Accreditation Committee). As Provider Status, he took part in the accreditation of the congress and course held in Turkey and paved the way for Turkish hematologists in CME credits.

He served as the founding president of the Cellular Therapy and Regenerative Medicine Association, which was founded in 2008.

In 2011, he became the founding president of the Geriatric Hematology Society.

He is the 'Honorary President' of the World Apheresis Congress (WAA) held in 2012. Having previously served on drug licensing and ethics committees at the Ministry of Health, Dr. Ilhan; He served as the Chairman of the Photopheresis-Apheresis Commission and the Chairman of the Bone Marrow Transplant Scientific Committee, as well as the Chairman of the National Organ Tissue Cell Coordination Committee, the Cord Blood Scientific Committee and the Stem Cell Research Committee.

He is the founding chairman of the KÖK CELL FOUNDATION.

He played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). With more than 300 publications in Pub-Med registered journals, Dr. Ilhan's; It has over 5000 citations and a H Factor of 34, 1050 EHA-CME credits. It has the Platinum CME certificate of the European Hematology Association.

KÖKTEN SOLUTION, TELEHEMATOLOGY, HEMAPHERES, CANCER STEM CELL has 4 trademarks/patents.

He is currently the President of Ankara Medical Association.

Having served for 50 years at Ankara University Faculty of Medicine, Prof. Dr. Osman İlhan started to work at Private Koru Ankara Hospital as of January 1, 2023.

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)
Acute Leukemia, Chronic Leukemia Treatments
Hodgkin Lymphoma, Non-Hodgkin Lymphoma Treatments
Multiple Myeloma Treatments
MDS, Aplastic Anemia, ITP, TTP Treatments
Hypercoagulability, Hereditary Thrombophilia Treatments
Therapeutic Apheresis, Photopheresis
Elderly Hematology Diseases

International Society of Hematology (ISH)
International Bone Marrow Transplantation Registry (IBMTR)
International Society of Hematotherapy and Graft Engineering (ISHAGE)
International Conference for Apheresis (ICFA)
World Apheresis Association (WAA)
American Society of Hematology (ASH)
American Society for Blood and Marrow Transplantation (ASBMT)
American Society for Apheresis (ASFA)
European Hematology Association (EHA)
European Bone Marrow Transplantation (Central No:117)
European Society for Hemapheresis (ESFH)
European Organization for Research and Treatment of Cancer (EORTC) (Centre: 973)
Italian Society of Haemapheresis (SIDE)
Aplastic Anemia Working Party Membership (EBMT)
Aplastic Anemia and MDS Foundation
Turkish Society of Hematology
Turkish Hemapheresis Association
Turkish Cancer Research and Control Institution
Turkish Internal Medicine Association
Blood Products and Transfusion Association
Infectious Diseases Association

TURKISH PUBLICATIONS

Yalçın A, Sayar H, Kutlu M, İlhan O, Yurtken S Hemofolia A and sickle cell trait coexistence in a case.
Hematology 215-220, 1987
 
Şardaş OS, Uysal A, Koç H, İlhan O Application of high-dose chemotherapy and autologous bone marrow transplantation in small cell lung cancers.
Aegean Medical Journal 28(4):1763-, 1989
 
Sardaş OS,Koç H,İlhan O, Akan H,Atakurt Y, Keskin G,Ilıman N: The Value of Serum Total Lactic Dehydrogenase Enzyme and Isoenzymes in Diagnosis and Remission Periods in Acute Lymphoblastic and Acute Non-Lymphoblastic Leukemias.
GATA Bulletin 31:569?576, 1989.
 
Şardaş OS, Koç H, İlhan O,Akan H, Atakurt Y, Keskin G,Ilıman N: Serum Lactic Dehydrogenase Levels and Isoenzymes as Activity Criteria Before and After Treatment in Malignant Lymphomas.
Journal of Optimal Medicine, 2(3):95?100, 1989.
 
Şardaş OS, Koç H, İlhan O, Akan H: Current Treatment Approach in Small Cell Lung Cancer.
Turkey Clinics, 9(6):423?428, 1989.
 
Şardaş OS, Koç H, İlhan O, Akan H, Süyür G: Serum Immunoglobulin levels in Breast Cancer.
Journal of Biochemistry, XIV(2): 39?43, 1989.
 
Şardaş OS, Koç H, İlhan O,Akan H, Beksaç M,Keskin G,Türker A: A Case of Acute Myeloblastic Leukemia Developing Secondary to Long-Term L?PAM (Melphelan) Use.
UU Faculty of Medicine Rapier. 42(3):441?448, 1989.
 
Sardaş OS, Uysal VA, Koç H, Erdoğan F, İlhan O, Akan H: Pretreatment Distribution of Lactic Dehydrogenase Levels and Isoenzymes in Hodgkin and Non-Hodgkin lymphomas.
Ankara Medical Bulletin, 11:299?309, 1989.
 
Şardaş OS, Koç H, İlhan O, Akan H, Uysal A: Clinical Features and Treatment of Hairy Cell Leukemia (due to 10 cases).
Mediterranean University. Journal of the Faculty of Medicine 4(4):1?8, 1989
 
Şardaş OS, İlhan O, Koç H, Akan H: Results Obtained with Aclasinomycin and Cytosine in Acute Nonlymphoblastic Leukemia and Chronic Myelocytic Leukemia Blastic Crisis.
Journal of Internal Medicine 1(2):1?5, 1989.
 
Şardaş OS, Beksaç M, Koç H, İlhan O, Akan H,Tolunay Ö, Arasil E: Extramedullary nonsecretory plasmacytoma.Report of two cases.
Journal of Ankara Medical School, 11(2):440?451, 1989.
 
Şardaş OS, Koç H, Uysal A, Beksaç M, İlhan O, Akan H: High-Dose Chemotherapy and Autologous Bone Marrow Transplantation in Refractory Malignant Lymphomas (First application results).
Hacettepe Medical Journal 22(3):215?225, 1989.
 
İlhan O, Özdemir N, Özdemir İ Serum immunocomplexes in renal anmyloidosis.
Uludag Medical Faculty Journal 17(1):11-15, 1990
 
Şardaş OS, Akan H, Koç H, İlhan O, Beksaç M, Yıldırım B: Comparison of empirical use of Ceftazidime + Amikacin and Piperacillin + Amikacin Combinations in Febrile Neutropenic Cases.
Turkiye Klinikleri Research Journal 9:36-38, 1991
 
Şardaş OS, Koç H, İlhan O, Akan H, Beksaç M: Allogeneic Bone Marrow Transplantation in Chronic Myelogenous Leukemia.
Journal of Ankara Medical School, 12(2):1?9, 1990.
 
Şardaş OS, Koç H, İlhan O, Akan H, Beksaç M: Application of Autologous Bone Marrow Transplantation and High-Dose Chemotherapy as a Treatment Option in Refractory Hodgkin Lymphoma.
Cukurova Medical Faculty. der. 15(3):225?231, 1990.
 
Akan H, İlhan O, Ataoğlu H, Arman D, Koç H, Beksaç M, Şardaş OS: Candida Sinusitis in a neutropenic case.
Journal of Infection 4(2):333?339, 1990.
 
Şardaş S, Şardaş OS, Çuhruk H, Furtun Y, Karakya AE, İlhan O: The relationship between plasma cholinesterase activity and malignant diseases.
Journal of Ankara Medical School 12(2):199-202, 1990
 
Şardaş OS, Akan H, Beksaç M, İlhan O, Koç H, Güneyli A. Immunphenotyping in Acute Leukemias.
Ankara Medical Faculty Journal 43(4): 915?924, 1990
 
Şardaş OS, İlhan O, Koç H, Akan H, Beksaç M, Arslan Ö: Mitoxantron + Etoposide, Mitoxantron + High-dose Cytosine Arabinoside applications in refractory and early relapsing acute leukemia.
Turkish Journal of Oncology, Vol. 5(3?4), 1043?1048, 1990
 
Şardaş OS, İlhan O, Akan H, Arslan Ö: New chemotherapy approaches in adult refractory and early relapsed acute leukemia.
Turkiye Klinikleri, 10(4):310?316, 1990.
 
Şardaş OS, İlhan O, Koç H, Beksaç M, Akan H, Gürman G, Arslan Ö: Mitoxantrone+High Dose ARA?C in The Treatment of Adult Refractory or Early Relapsed Acute Leukemia.
Journal of Ankara Medical School Vol 12(4): 299?306, 1990
 
İlhan O, Sardaş OS, Akan H, Koç H, Beksaç M, Ateş K, Bulay O: Primary Hodgkin's Disease of The Ovary: A Case Report.
Cancer, The Turkish Journal of Cancer 21(1):40?43, 1991.
 
Şardaş OS, İlhan O, Gürman G. Chemotherapy in acute myeloblastic leukemia.
Turkey Clinics 11(2), 109-113, 1991.
 
Ilhan O, Beksac M, Erekul S, Sardas OS. A case of hereditary spherocytosis with hemochromatosis and elevated Hb F.
Journal of Optimal Medicine 4(1):40-42, 1991
 
İlhan O, Şardaş OS, Erekul S, Koç H. Investigation of bone marrow involvement in lung cancers.
Ankara Medical Faculty Journal 44:199-212, 1991.
 
İlhan O, Hairy Cell Leukemia.
Clinical Series 2(3):, 128-132, 1991.
 
Ünal A, Yücesoy M, Ökten T, İlhan O, Şardaş OS. Immunothrombocytopenia due to non-Hodgkin lymphoma.
Erciyes Medical Journal 13:120-124, 1991.
 
Sardas

OS, Koç H, İlhan O, Akan H, Beksaç M. High-dose chemotherapy and autologous bone marrow transplantation in intermediate and high-risk non-Hodgkin lymphoma for consolidation after remission or in cases with early relapse in this group.
Faculty of Medicine Mecm. 54:567-574, 1991.
 
İlhan O, Dalva K, Beksaç M, Gönenç F, Akan H, Şardaş OS. Determination of serum folic acid levels in the anemia of uremic patients under peritoneal dialysis.
Journal of Ankara Medical School 13(3):211-216,1991.
 
Şardaş OS, Beksaç M, Koç H, İlhan O, Akan H, Gürman G. Retrospective analysis of an acute leukemia case.
Cerrahpaşa Faculty of Medicine Der 22: 593-599,1991
 
Şardaş OS, İlhan O, Koç H, Akan H, Sezer MT, Türker A. Serum cholesterol and triglyceride values ​​in hematological malignancies.
Optimal Journal 4(4):202-205, 1991
 
Şardaş OS, İlhan O, Akan H, Beksaç M, Koç H, Gürman G, Türker A Lymphocyte subtyping in chronic lymphocytic leukemia.
Cancer 21(2):61-65,1991
 
Şardaş OS, İlhan O, Koç H, Beksaç M, Akan H, Konuk N, Gürman G, Aydoğdu İ, Köktürk O.N. Results of interferon alfa 2-b treatment in chronic myelogenous leukemia.
Journal of Ankara Medical School 14 (1):1-10,1992
 
Yıldırım B, Şardaş OS, Konuk N, İlhan O. The effects of drugs used in the treatment of malignant lymphoma on gonadal functions.
Ankara Medical Faculty Journal 45(3):457-464, 1992
 
İlhan O. Classification of acute leukemias.
Turkey Clinics 12:468-471, 1992
 
İlhan O, Interferon therapy in leukemias.
Turkey Clinics 10(2):472-476, 1992
 
Akan H, Beksaç M, Koç H, İlhan O, Gürman G, Arslan Ö, Konuk N, Uysal A Autologous peripheral blood stem cell transplantation: An alternative.
THOD, II(3):1-3, 1992
 
Aydoğdu İsmet, Gürman G, Akan H, İlhan O, Koç H, Beksaç M, Konuk N, Uysal A: The relationship of smoking with blastic crisis and life span in chronic myeloid leukemia.
Optimal Journal 5(3):115-117,1992.
 
Koç H, Ataoğlu H, Sentürk T, Özsökmen D, Akan H, Beksaç M, İlhan O, Şardaş OS Comparison of the efficacy of oral fluconazole and oral nystatin in the prophylaxis of fungal infection in patients receiving acute leukemia induction chemotherapy.
Turk J Infection (Journal of Infection): 6(4): 235-239,1992
 
İlhan O, Özcan M Use of danazol in hematology.
Turkish Journal of Clinical Medical Sciences 13:487-489, 1993
 
Akan H, İlhan O, Koç H, Beksaç M The use of ondansetron as an antiemetic in cancer treatment.
Journal of Medicine and Treatment, 6(9):560-563, 1993
 
İlhan O, Koç H, Beksaç M, Akan H, Aydoğdu İ, Konuk N, Uysal A, Şardaş OS Cyclosporine A (CsA) + Methyl prednisone (MP) and Antilymphocyte Globulin (ALG) + Methyl Prednisone treatment in aplastic anemia: İbni Sina Hospital Results.
GATA Bulletin 35: 893-897, 1993
 
Uysal A, Akan H, Gürman G., Konuk N., Beksaç M., Koç H., İlhan O., Arslan Ö., Şardaş O.S. Bone Marrow Transplants from Blood Type Inappropriate Donors; Initial results
Turkish Journal of Hematology -Oncology 3(3) : 150-153, 1993.
 
İlhan O, Özcan M, Koç H, Beksaç M, Akan H, Konuk N, Gürman G, Aydoğdu İ Danazol Treatment in Treatment-Resistant Chronic Immune Thrombocytopenia: Preliminary Results
THOD IV(1): 5-9, 1994
 
Uysal A., İlhan O., Sencer H., Aydoğdu İ., Konuk N., Beksaç M., Akan H., Koç H. "Hairy Cell" Leukemia: Clinical and Morphological Study.
Turkish Journal of Medicine 1(1): 3-9 1994
 
Arslan Ö, İlhan O Hemapoetic growth factors.
Doctor's Journal 2(1):50-55, 1994
 
Özcan M, İlhan O Purging practices in autologous bone marrow transplantation to purify the bone marrow from malignant cells.
Physician Journal 2(2):123-128, 1994.
 
Koç H, Arslan Ö, Gürman G, İlhan O, Akan H, Beksaç M, Konuk N Syngeneic Bone Marrow Transplantation: Due to a case.
THOD IV(2): 117-120,1994.
 
İlhan O, Koç H, Beksaç M, Akan H, Konuk N, Arslan Ö, Gürman G, Özcan M, Uysal A, Şardaş OS High Dose cytosine arabinoside + mitoxantrone or mitoxantrone + etoposide in refractory or early relapsed acute non-lymphoblastic leukemia: 5 years experience in İbni Sina Hospital.
Turkish Journal of Cancer 24(4):188-194 1994.
 
Kaya M, İlhan O Current treatment in multiple myeloma.
Doctor's Journal 2(5-6):297-302, 1994
 
Güngör A, Dikmen E, İlhan O, Erekul S, Ökten İ Transdiaphragmatic Dumbbell bronchogenic cyst.
G K D Draw Magazine 2:391-394, 1994
 
Gürman G, Akan H, Koç H, Uysal AR, Çorapçıoğlu D, İlhan O, Beksaç M, Konuk N, Arslan Ö, Aydoğdu İ, Aylı M,Uysal A, Erdoğan G. Thyroid functions after Bone Marrow Transplantation.
THOD IV(3): 140-145, 1994
 
İlhan O, Gürman G, Uysal A, Koç H, Beksaç M, Akan H, Konuk N, Arslan Ö, Özcan M: GM-CSF administration after allogeneic bone marrow transplantation.
THOD IV(3): 162-166, 1994
 
Akan H, Koç H, Aydoğdu İ, İlhan O, Beksaç M, Gürman G, Konuk N, Uysal A Comparison of the efficacy of sulbactam/cefoperazone + amikacin and ceftazidime + amikacin in a single-center randomized study in febrile neutropenic patients.
Microbiol Bulletin, 29: 131- 135, 1995
 
Gürman G, Kaya M, Koç H, Akan H, İlhan O, Erol Ç, Konuk N, Uysal A, Beksaç M. Cardiologic evaluation of bone marrow transplantation patients.
Turk J Med Res 13(2):50-54 1995
 
Gürman G, Sencer H, Uysal A, Koç H, İlhan O, Akan H, Beksaç M, Konuk N, Özcan M Hemorrhagic cystitis after Bone Marrow Transplantation: The place of electron microscopic study in differential diagnosis -first results-
Journal of Optimal Medicine 8(2): 61-67,1995
 
İlhan O, Konuk N, Arslan Ö, Beksaç M, Koç H, Akan H, Gürman G, Özcan M Use of Clodronate in the treatment of bone pain in Multiple Myeloma.
THOD, V(2), 1995
 
Koç H, Akan H, İlhan O, Gürman G, Özcan M, Arslan Ö, Arat M, Aydoğdu İ, Beksaç M, Konuk N, Uysal A Relationship between cytokine levels and aplasia period following high dose chemotherapy without stem cell rescue in malignant lymphoma .
THOD.Volume VI(1):6-12, 1996
 
İlhan O, Arat M, Özcan M, Akar H, Gürgey A: Pancytopenia due to human parvovirus B19 infection in hereditary hemolytic anemia: Case report and review of the literature.
THOD Vol VI(1):48-52, 1996
 
Koç H, İlhan O, Akan H Bone marrow transplantation activity in Ankara University Ibni Sina Hospital
THOD Vol VI (2):82-86, 1996.
 
Akan H, Koç H, İlhan O, Beksaç M, Gürman G, Arslan Ö, Özcan M, Dilek İ, Konuk N, Uysal A Autologous peripheral blood stem cell transplantation : a preliminary report from Ibn-i sina hospital.
Medical Bulletin of Istanbul Medical Faculty 1996 (in press)
 
İlhan O, Özcan M, Dalva K, Koç H, Akan H, Konuk N, Arslan Ö, Sunguroğlu A, Beksaç M. In the treatment of chronic myelocytic leukemia, the cytogenetic efficacy of the long-term use of high-dose interferon alfa-2a and low-dose cytosine arabinoside in combination with polymerase chain examination by reaction method: preliminary results of a multicenter clinical study Ibn-i Sina.
Journal of Medical Biotechnology and Molecular Medicine 1(1): 20-26, 1996.
 
İlhan O, Beksaç M, Özcan M, Koç H, Akan H, Gürman G. The role of autologous whole blood transplantation in the treatment of primary refractory multiple myeloma.
Turkish Journal of Hematology Oncology 6;3: 171-173, 1996
 
İlhan O, Beksaç M, Özcan M, Koç H, Akan H, Gürman G. The role of autologous whole blood transplantation in the treatment of primary refractory multiple myeloma.
Turkish Journal of Hematology Oncology 6;3: 171-173, 1996
 
Koç H, İlhan O, Akan H, Gürman G, Özcan M, Arslan Ö, Konuk N, Uysal A, Beksaç M. Bone marrow transplantation activity in Ankara University Ibni Sina Hospital.
Turkish Journal of Hematology Oncology 6;2:82-86, 1996.
 
Aydoğdu İ, Tayfun E, Akan H, Koç H, Beksaç M, İlhan O, Konuk N, Uysal A. Clinical course in idiopathic thrombocytopenic purpura: results of a series of 62 patients.
Turkish Journal of Medicine 4;2:73-76, 1997.
 
Arslan Ö, İlhan O, Uysal A, Dilek İ, Özcan M, Koç H, Akan H, Gürman G, Konuk N, Beksaç M. Sequential autologous peripheral stem cell transplantation in breast cancer with liver metastases: due to two cases.
Cancer Agenda 2(4):134-137 1997
 
İlhan O, Arslan Ö, Arat M. Peripheral blood stem cell transplantation technique and application principles
Journal of Hematology-Oncology Current Review1:71-78, 1999
 
KML compilation
Journal of Hematology-Oncology Current Review1:71-78, 1999
 
İ.Dilek, R.İdilman, S.Fenkçi, C.Üstün, H.Koç, O.İlhan, H.Akan,. Immunsupressive Therapy-Induced Hepatotoxicity in Patients with Aplastic Anemia.
Turkish J Hematology: 17(3):111-117, 2000.
 
R.İdilman, C.Üstün, Ö.Arslan, M.Özcan, M.Arat, H.Bozkaya, M.Bozdayı, T.Şengezer, Ö.Uzunalimoğlu, A.Dökmeci, O.İlham, H.Koç, H. Flowing. The incidence of hepatitis G virus in patients with hematological malignancy. The relationship to the number of blood and blood products transfucions.
Turkish J Hematology: 17:67-76, 2000.
 
Coşkun HŞ, Arat M, Arahan S, Kumbasar Ö, İlhan O, Koç H. Idiopathic Pulmonary Hemosiderosis A Case Report and Review of the Literature
Ankara University Faculty of Medicine Journal 54(1), 77-81, 2001
 
H.S.Coskun, O.Er, O.Ilhan. Multiple Myeloma: Current Approaches
Erciyes Medical Journal 2001: 23(2):83-90
 
O. İlhan Chronic Myelocytic Leukemia
III. National Internal Medicine Congress Book 2001: 40-43
 
O. İlhan New treatment methods in Imminorology 37th National Neurology Congress book 2001: 79-85
 
Ö.Arslan, H.Ş Coşkun, M.Arat, E.Soydan, M.Özcan, G.Gürman, H.Çelebi, T.Demirer, H.Akan, O.İlhan, N. Konuk, A.Uysal, M .Beksac, H.Koç. The role of ABO incompatibility in allogeneic peripheral blood stem cell transplantation. Turk J Haematol. 19(3): 402-409. 2002.
 
Ö.Arslan, M.Arat, S.Koçak, E.Ayyıldız, O.İlhan. Therapeutic plasma exchange and the clinical applications. Turk J Haematol. 20(1): 7-17, 2003.
 
Osman İlhan et al. Transplantation and Apheresis. Turkey Clinics Hematology, April 2003; 1(1):9-15
 
Osman İlhan et al.Transplantation and Photopheresis. Turkey Clinics Hematology, April 2003; 1(1):92-96
 
Kurt Yüksel M, Arat M, Arslan Ö, İlhan O. Autologous platelet collection and storage to support thrombocytopenia in aleukemia patient with platelet alloimmunization undergoing chemotherapy. Turkish Journal of Haematology 2003; 20: 233-236
 
G. Gürman, M. Arat, P. Topçuoğlu, EA Soydan, O. İlhan, M. Beksaç, M. Özcan, N. Konuk, A. Uysal

, H. Koc, O. Arslan, H. Akan. Allogeneic hematopoietic cell transplantation in chronic myelocytic leukemia: Comparison of standard dose versus reduced dose preparation regimens. Turkish J Haematol 2003; 20 (Suppl): 67 (oral)
 
. EA Soydan, M. Arat, T. Bulakbaşı, P. Topçuoğlu, Ö. Arslan, M. Özcan, G. Gürman, O. İlhan, M. Beksaç, H. Akan. Two-year follow-up of our patients for whom allogeneic hematopoietic cell transplantation was decided: the effect of transplantation rate on early transplantation success. Turkish J Haematol 2003; 20 (Suppl): 52 (Verbal)
 
Beksac, EA. Soydan, M. Arat, P. Topçuoğlu, MK. Yüksel, Sk Toprak, M. Özcan, G. Gürman, O. İlhan, H. Akan. Ankara University Faculty of Medicine Hematology Department's experience that high-dose chemotherapy with stem cell support prolongs survival in multiple myeloma cases compared to conventional treatments. Turkish J Haematol 2003; 20 (Suppl): 71 (Verbal)
 
ES Koytak, EA Soydan, M. Arat, P Topçuoğlu, Ö Arslan, M Beksaç, O İlhan, A Uysal, N Konuk, M Özcan. High-dose chemotherapy with autologous stem cell support in Hodgkin lymphoma cases: Avicenna's experience. Turkish J Haematol 2003; 20 (Suppl): 74 (Verbal) "THD Young Researcher Award"
 
MK Yüksel, O. İlhan, M. Arat, P. Topçuoğlu, E. Soydan, M. Beksaç, M. Özcan, Ö. Arslan, G. Gürman, N. Konuk, A. Uysal, H. Akan. Retrospective analysis and overall survival of 86 patients diagnosed with primary myelodysplastic syndrome according to the Bournemouth scoring system. Turkish J Haematol 2003; 20 (Suppl):109
 
P. Topçuoğlu, M. Arat, EA Soydan, E. Ayyıldız, O. İlhan, M. Beksaç. The effect of diagnosis, stem cell collection and time to transplantation in patients receiving high-dose chemotherapy. Turkish J Haematol 2003; 20 (Suppl):143

FOREIGN PUBLICATIONS

Şardaş S, Çok İ, Şardaş OS, İlhan O, Karakaya AE Polymorphic N-acetylation capacity in breast cancer patient. Int J Cancer 46:1138-1139, 1990
 
Şardaş O.S., Koç H., İlhan O., Akan H., Beksaç M.: Hepatic failure after bone marrow transplantation. Blood 70. 2265, 1990.
 
Şardaş O.S., Beksaç M., Koç H., İlhan O., Akan H., Gürman G. Tumor Necrosis Factor a in human bone marrow recipients. Blood 76 (12): 2639, 1990.
 
Şardaş OS, Koç H, İlhan O, Akan H, Beksaç M: Hepatic Failure After Bone Marrow Transplantation. Blood 75(11):2265, 1990. (Letter)
 
Şardaş OS, Beksaç M, Koç H, İlhan O, Akan H, Gürman G: Tumor Necrosis Factor in Human Bone Marrow Recipients. Blood, 67(12):2639, 1990. (Letter)
 
Beksaç M, Özcan M, Koç H, Akan H, İlhan O, Şardaş O. Circulating endogenous granulocyte colony-stimulating factor levels after bone marrow transplantation. Blood 79: 2946-2947, 1992. (Letter)
 
Beksaç M, Akan H, Koç H, İlhan O, Ertürk S, Güneyli A, İkizünal Y, Şardaş O. Glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols. Med Oncol & Tumor Pharmacother Vol 9(2):101-105,1992
 
Akan H, Koç H,Beksaç M, İlhan O, Gürman G, Aydoğdu İ, Şardaş OS.: Case Report: Complications of Bone Marrow Transplantation, A long way to run. Libri Oncol, 22(3):219-221, 1993
 
Beksaç M, Ertürk S, Akan H, Koç H, İlhan O. The clinical correlations of serum tumor necrosis factor-alpha levels in acute leukemias. A predictor of response and relapse? Leukemia, 7(11): 1773-1776, 1993
 
Karakaya AE, Çok İ, Şardaş S, Gürman G, İlhan O Erythrocyte membrane stearic to oleic acid ratio in lymphoma patients. Pharmacology Toxicology 73: Supl 2:70, 1993
 
Beksaç M, Özcan M, Koç H, Akan H, İlhan O.: Relevance of serum G-CSF levels in bone marrow transplantation patients. Experimental Hematology 23(6): 480-481, 1994
 
Arslan Ö.,Akan H.,Beksaç M.,İlhan O.,Koç H., Konuk N.: Terminal Deoxytidyl Transferase positivity in acute nonlymphoblastic leukemia. Leukemia 8 (6) :1067 , 1994. (Letter)
 
Akan H, Beksaç M, Aydoğdu İ, Koç H, İlhan O, Özcan M.: Peripheral T Cell Receptors ab and gd in patients with Hodgkin's lymphoma. Br J Haematol 87(3):544-547 ,1994
 
İlhan O, Beksaç M, Koç H, Akan H, A. Keskin, Arslan Ö, Gürman G, Özcan M, Konuk N, Uysal A.: HLA DR frequency in Turkish aplastic anemia patients and the impact of HLA DR2 positivity in response rate in patients receiving immunosuppressive therapy. Blood 86(5): 2055, 1995. (letter)
 
İlhan O, Aydoğdu İ, Beksaç M, Koç H, Akan H, Konuk N, Uysal A.: Combination therapy in Aplastic anemia. Indian J Med Res (102) :143-146,1995
 
İlhan İ, Erekul S, Ateşalp S, İlhan O, Akar N. p53 codon 213AG polymorphism in Turkish population. Pediatric Hematology and Oncology 12:499-501, 1995
 
Gürman G, Kahveci G, Akan H, İlhan O, Koç H, Beksaç M, Konuk N, Uysal A.: Allogeneic peripheral blood stem cell transplantation as a second transplant for severe aplastic anemia. Bone Marrow Transplant 15: 485-488, 1995
 
İlhan O, Uysal A, Aydoğdu İ, Beksaç M, Akan H, Koç H: Mitoxantrone and cytosine arabinoside in previously untreated patients with acute non-lymphocytic leukemia. Haematologica 27(2):93-97, 1996
 
Arslan O, Akan H, Koç H, BeksacM, İlhan O, Özcan M, Yalçın S, Gürman G, Konuk N, Uysal A Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen. Bone Marrow Transplantation 18:261-264, 1996
 
Arslan Ö, Akan H, Beksaç M, Özcan M, Koç H, İlhan O, Konuk N, Uysal A Lack of prognostic value of CD34 in adult AML. Leukemia and Lymphoma, 1996 (letter)
 
Koç H, Gürman G, Arslan Ö, Özcan M, Akan H, İlhan O, Konuk N, Beksaç M, Uysal A. Is there an increased risk of graft versus host disease after allogeneic peripheral blood stem cell transplantation? Blood 88(6):2362-4, 1996
 
İlhan O, Koç H, Akan H, Gürman G, Arslan Ö, Özcan M, Arıkan N, Sencer H, Konuk N, Uysal A, Beksaç M Hemorragic cysttits as a complication of bone marrow transplantation J of Chemotherapy 9:56-61, 1996
 
İlhan O, Beksac M, Arslan Ö, Özcan M, Koç H, Akan H. HLA DR2: A predictive marker in response to cyclosporine therapy in aplastic anemia Int J Hematol 66:291-295,1997
 
Koç H, Arslan Ö, Gürman G, Akan H, Özcan M, İlhan O, Aydoğdu İ, Arat M, Beksaç M, Konuk N, Uysal A. The use of high dose chemotherapy plus granulocyte colony stimulating factor for the salvage of refractory ort resistant relapse malignant lymphoma patients without stem cell support. Acta Haematol 98(3):136-139 1997.
 
Akan H, Koç H, Arslan Ö, Beksaç M, İlhan O, Gürman G, Özcan M. Febrile neutropenia in a bone marrow transplantation center. Int J of Antimicrob Agents 8:127-130 1997
 
İlhan O, Akan H, Koç H, Gürman G, Arslan Ö, Özcan M, Erdi H, Erdem C, Konuk N, Uysal A, Beksac M Incidence of graft versus host disease in allogeneic bone marrow transplantation in a single center study from Turkey . Hematol Cell Ther 39:133-36, 1997
 
Üstün C, Koç H, Karayalçın S, Akyol H, Gürman G, İlhan O, Akan H, Özcan M, Arslan Ö, Konuk N, Uysal A,. Hepatitis B Virus infection in allogeneic bone marrow transplantation. Bone Marrrow Transplantation 20:289-96, 1997
 
Koç H. Gürman G,Arslan Ö, Özcan M. Dilek İ, Akan H, İlhan O, Konuk N, Beksaç M, Uysal A. Allogeneic peripheral blood stem cell transplantation: Is there an increased risk of graft vs host disease in leukemia patients ? Journal of Chemotherapy 9(5):371-376 1997.
 
Aydoğdu İ, Koç H. İlhan O, Gürman G, Akan H, Beksaç M, Konuk N, Uysal A, Özerol E. Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphoma. Hematologia 28(4):207-213 1997.
 
Dilek İ, Demirer T, Üstün C, Arat M, Koç H, Beksaç M, Erdi H, Anadolu R, Özcan M, İlhan O, Akan H. Acquired ichthyosis associated with chronic graft versus host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. Bone Marrow Transplant 21:1159-1161 1998.
 
Arslan Ö, Gürman G, Dilek İ, Özcan M, Koç H, İlhan O, Akan H, Konuk N, Uysal A, Beksaç M. Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey Haematologia 29(1):59 -63 1998.
 
Arslan Ö, Seferoğlu A, Gürman G, İlhan O, Koç H. Resistant graft failure overcome with allogeneic peripheral blood plus bone marrow stem cells. Haematologia 29(1):47-51, 1998.
 
Beksaç M, Arslan Ö, Koç H, Akan H, İlhan O, Arat M, Özcan M, Gürman G, Konuk N, Uysal A. Randomized unicenter trial for comparison of three regimen in de novo adult acute nonlymphoblastic leukemia. Medical Oncol 15:183-190 1998.
 
Arslan Ö, Üstün C, Arat M, Çelebi H, Akan H, Beksaç M, İlhan O, Gürman G, Özcan M, Konuk N, Uysal A, Koç H. Allogeneic peripheral blood stem cell transplantation in acute nonlymphoblastic leukemia. Hematological Oncology 1999 (in press)
 
Üstün C, Arslan Ö, Beksaç M, Koç H, Gürman G, Özçelik T, Yılmaz B, İlhan O, Akan H, Özcan M, Demirer T, Uysal A, Konuk N, Arat M, Dilek İ, Çelebi H, Çoşkun HŞ . A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center, a focus on the incidence of GVHD and relapse. The Biology of Blood and Marrow Transplantation 1999;5(1):28-35
 
Üstün C, İdilman R, Gürman G, Özcan M, Akyol G, Akan H, İlhan O, Beksaç M, Uysal A, Konuk N, Karayalçın S, Aylar Poyraz A, Thiel D V and Koç H. Hematopoietic stem cell transplantation in patients with non-replicative hepatitis B virus carrier is safe. Journal of Hepatology (in press)
 
Üstün C, Çelebi H, Arat M, Özcan M, Dilek İ, Gürman G, İlhan O, Koç H. Pure Red Cell Aplasia as a Complication of an ABO-incompatible Allo-PBSCT: successful sequential treatment with plasma exchange, high dose prednisolone , danazol and erythropoietin Ther Apher (accepted)
 
İlhan O, Arslan Ö, Arat M, Beksaç M, Akan H, Koç H, Dilek İ, Özcan M, Gürman G, Konuk N, Uysal A. The impact of CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation. Transfusion Science 20:69-71.1999
 
J.Marsh, H.Schrezenmeier, P.Marin, O.Ilhan, P.Ljungman, S. McCann, G.Socie, A.Tichelli, J.Passweg, J.Hows, A.Raghavachar, A.Locasciulli, A. Bacigalupo, on behalf of the EBMT severe aplastic anemia working party.. Prosective randomized mulitcenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with non-severe aplastic anemia:A report from the European Blood and Marrow Transplant (EBMT) Sever Aplastic Anemia Working Party Blood 93:2191-2195, 1999
 
O. İlhan, N.Üstkent, Ö.Arslan, M.Arat, F.Özkalemkaş, G.Öztürk, S.Beşışık Kalayoğlu, A.Özet, M.Tombloğlu, M.Arpacı, E.Ovalı, S.Anak. On Behalf of Turkish Apheresis Group. National Survey of Hemapheresis practice in Turkey (1998). Transfucion Science 22:195-201,2000.
 
Ö.Arslan, H.Akan, M.Arat, K.Dalva, M.Özcan, G.Gürman, O.İlhan, N. Konuk, M.Beksaç, A.Uysal, H.Koç: Soluble adhesion molecules (sICAM- 1, sL-Selectin, sCD44) in healthy allogeneic peripheral blood stem cell donors primed with recombinant granulocyte-colony stimulating factor. Cytotherapy 2(4):259-265, 2000.
 
Ö.Arslan, H.Ş.Çoşkun, M.Arat, H.Çelebi, M.Özcan, G.Gürman, C.Üstün,T.Demirer, H.Akan, O.İlhan, N. Konuk, M. Beksaç, A.Uysal, H.Koç. Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of İbni Sina Hospital. Bone Marrow Transplantation, 25, 1229-1232, 2000.
 
M. Beksaç, M. Arat, H. Akan, H. Koç, O. İlhan, M. Özcan. Circulating CD44 and Intracelluler adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic lekemia patients during interferon alfa-2a treatment. Cancer 89; 1974-1481, 2000
 
G.Gürman, İ.Dilek, Ö.Arslan, M.Arat, M.Beksaç, O.İlhan, M.Özcan, H.Akan, K.Dalva, N.Konuk, A.Uysal, H.Koç The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation. Transfusion and Apheresis Science 24(1): 23-28, 2001
 
G.Gürman, H.Celebi, C.Üstün, M.Arat, O.İlhan, M.Özcan, Ö.Arslan, A.Uysal, H.Akan, M.Beksaç, N. Konuk, H.Koç Allogeneic Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia Therapeutic Apheresis 5(1):54-57, 2001.
 
M.Çetin, B.Eser, Ö.Er, A.Ünal, E.Kılıç, T.Patıroğlu, H.Senol Coşkun, M.Altınbaş, Ö.Arslan, O.İlhan Effects of DMSO on Platelet Functions and P-Selectin expression during Storage. Trasnfusion and Apheresis Science 24(2): 2001
 
Arat M., İlhan O, Akçağlayan E, Çelebi H, Koç H, Akan H. Treatment of extensive chronic scleradermatous graft-versus-host disease with high dose immunosupressive therapy and CD34+ autologous stem cell rescue. Blood 2001;98:892 (letter)
 
R. İdilman, C Üstün, Ö Arslan, M Özcan, M Arat, H Bozkaya, M Bozdayı, T Şengezer, Ö Uzunalimoğlu, A Dökmeci, O İlhan, H Koç, H Akan. The incidence of Hepatitis G Virusin patients with hematological malignancies:The relationship to the number of blood and blood products transfusions. Turkish Journal of Hematology 2000;17:67-76
 
O İlhan, Ş.Mine Bakanay, M.Arat, M.Özcan, H.Çelebi, G.Gürman, Ö.Arslan, H.Akan, C.Üstün, E.Akçağlayan, N.Konuk, A.Uysal, H. Ram. Treatment of Aplastic Anemia: Experience of Ibni Sina Hospital. Turk J Hematol 2001; 18(1):33-40.
 
An usual presentation of plasma cell dyscrasias: Cardiac Tamponade due to myelomatous infiltration. (Case report) M. Arat, V. Ulusoy, T.Demirer, A.Uysal, M.Özcan, S.Dinçer, O İlhan, H.Koç. Leukemia & Lymphoma, 2002, 43: 145-148.
 
Influence of Storage Time on Activation of Platelets Collected with CS 3000 Plus and Cobe Spectra Using Platelet Storage Containers : Sim Kutlay, Osman İlhan, Önder Arslan and Meral Beksaç. International Society for Apheresis, 2002; 6(1):82-85.
 
C.Üstün, M.Arat, Ç. Great, H.Akan, O.Ilhan, T.Ozcelik, R.E.Burgess, H.Koç. Extramedullary relapse following allogeneic sem cell transplantation in acute promyelocytic leukemia: the role of ATRA. haematologica. 2001. Oct; 86 (10): E31.
 
M.Özcan, C.Üstün, E.Akçağlayan, H.Akan, Ö.Arslan, O.İlhan, M.Beksaç, G.Gürman, T.Demirer, M.Arat, H.Çelebi, N.Konuk, A. Uysal, H.Koç. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2001 Mar; 27(5): 499-505.
 
G.Gürman, H.Celebi, C.Üstün, M.Arati O.İlhan, M.Özcan, Ö.Arslan, A.Uysal, H.Akan, M.Beksaç, N. Konuk, H. Koç. Allogeneic peripheral blood stem cell transplantation for sever aplastic anemia. Ther Apher. 2001. Feb; 5 (1): 54-7
 
G.Gürman, M.Arat, O.İlhan, N.Konuk, M.Beksaç, H.Çelebi, M.Özcan, Ö.Arslan, H.Akan, A.Uysal, H.Koç, Allogeneic hematopoietic cell transplantation without myeloblative conditioning for patients with advanced hematologic malignancies. Cytotherapy 2001; 3(4): 253-260.
 
T.Demirer, O. İlhan, M. Arat, Y. Genç, M. Özcan, K. Dalva, H. Çelebi, M. Beksaç, H. Akan, G. Gürman, N. Konuk, A.Uysal, Ö. Arslan, H.Koç. CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation. J.Clin Apheresis. 2001; 16 (2): 67-73.
 
G.Gürman, İ.Dilek, Ö.Arslan,M.Arat, M.Beksaç, O.İlhan, M.Özcan, H.Akan, K.Dalva, N.Konuk, A.Uysal, H.Koç. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation. Transfus Apheresis Sci. 2001 Feb; 24(1):23-8.
 
M. Çetin, B.Eser, O.ER, a.Unal, E.Kılıç, T.Patıroğlu, H.S.Coşkun, M.Aştinbaş, Ö.Arslan, O.İlhan. Effects of DMSO on platelet functions and P-selectin expression during storeage. Transfusion and Apheresis Science 2001; 24(3), 261-7.
 
M. Arat, O. İlhan, E. Akçağlayan, H. Celebi, H. Koç, H. Akan. Treatment of extensive chronc sclerodermatous graft-versus-host disease with high-dose immunosuppressive therapy and CD34+ autologous stem cell rescue. blood. 2001. Aug 1;98(3): 892-3.
 
M.Arat, M.Beksaç, G.Gürman, M.Özcan, Ö.Arslan, E.Soydan, D.Yazman, P.Topçuoğşu, O.İlhan, H.Koç, A.Uysal, N.Konuk, H. Flowing. Allogeneic hematopoietic stem cell transplantation using iv Busulfan. Blood 98(11): 342b, 2001.
 
An usual presentation of plasma cell dyscrasias: Cardiac Tamponade due to myelomatous infiltration. (Case report) M. Arat, V. Ulusoy, T.Demirer, A.Uysal, M.Özcan, S.Dinçer, O İlhan, H.Koç. Leukemia & Lymphoma, 2002, 43: 145-148.
 
Influence of Storage Time on Activation of Platelets Collected with CS 3000 Plus and Cobe Spectra Using Platelet Storage Containers : Sim Kutlay, Osman İlhan, Önder Arslan and Meral Beksaç. International Society for Apheresis, 2002; 6(1):82-85
 
H.Akan, M.Beksaç, İ.Aydoğdu, H.Koç, O.İlhan, M.Özcan. Peripheral T cell receptors ?ß and ?? in patients with hodgkin's lymphoma. British Journal of Haematology 87: 544-547, 1994.
 
O. İlhan, A.Uysal, İ.Aydoğdu, M.Beksaç, H.Akan, H.Koç. Mtoxantrone ancd cystosine arabinoside in previousy untreated patients with acute non-lymphomatic leukemia. Haematologia 27: 93-97, 1996.
 
İ.Aydoğdu, O.İlhan, M.Beksaç, H.Koç, H.Akan, N.Konuk, A.Uysal,. Serum erythropoietin levels in patients with leukemia on cytostatic treatment. Haematologia 29:133-137, 1998.
 
T.Demirer, M.Aylı, M.Özcan, M.Günel, R.Haznedar, M.Dağlı, T.Fen, S.Dinçer, Ö.Arslan, G.Gürman, S.Demirer, G.Özet, A. Uysal, N. Konuk, O. İlhan, H. Koç, H. Akan. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF. BrJ Haematol. Feb; 116(2): 468-474, 2002.
 
S.Kutlay, O.Ilhan, ÖçArslan, M.Beksaç,. Influence of storage time on activation of platelets collected with CS 3000 Plus and Cobe Spectra using platelet storage containers. Ther Apher Feb 6 (1): 182-185, 2002.
 
T.Demirer, M.Dagli, O.Ilhan, M.Ayli, R.Haznedar, T.Fen, N.Günel, Y.Genç, M.Arat, M.Özcan, Ö.Arslan, E.Seyrek, S. Dinçer, T.Üstün, N.Ustael, H.Koç, O.Muftuoglu, H.Akan. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters. Bone Marrow Transplant 29; 893-897, 2002.
 
T.Demirer, O.Ilhan, M.Ayli, M.Arat, M.Dagli, M.Ozcan, R.Haznedar, Y.genc, T.Fen, E.Ayyıldız, S.Dinçer, Ö.Arslan, G. Gürman, N. Konuk, K.Dalva, A.Uysal, H.Koç, G.Özet, H.Akan. Monitoring of peripheral blood .
 
İ.Tek, Ö.Arslan, M.Arat, M.Özcan, B.Akbağ, O. İlhan. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange. Transfusion and Apheresis Science 28; 3-7, 2003.
 
M.Beksaç, H.Celebi, H.Sargın, A.Yalçın, P.Topçuoğlu, S.Kalayoğlu-Beşışık, C.Beyan, Ö.Arslan, M.Özcan, G. Gürman, O.İlhan, H.Akan. Role of pretransplantinterferan-alpha (IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogeneous leukemia (CML): results form three Turkish transplant centers. Bone Marrow Transplant 31; 897-904, 2003.
 
A.E.Unal, S.Bayar, M.Arat, O.Ilhan. Malpositioning of Hickman catheters, left versus right sides attempts. Transfusion and Apheresis Science 28 (1): 3-9, 2003.
 
Tek I, Arslan O, Arat M, Ozcan M, Akdag B, Ilhan O. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange.
Transfus Apheresis Sci. 2003 Feb;28(1):3-7.C
 
Demirer T, Uysal VA, Ayli M, Genc Y, Ilhan O, Koc H, Dagli M, Arat M, Gunel N, Fen T, Dincer S, Ustael N, Yildiz M, Ustun T, Seyrek E, Abstract G, Muftuoglu O , Akan H. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.
Bone Marrow Transplant. 2003 May;31(9):755-61. A
 
Beksac M, Celebi H, Sargin D, Yalcin A, Topcuoglu P, Kalayoglu-Besisik S, Beyan C, Arslan O, Ozcan M, Gurman G, Ilhan O, Akan H. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.Bone Marrow Transplant. 2003 May;31(10):897-904.A
 
O. Ilhan, O. Arslan, M. Arat, E. Ayyildiz, M. Özcan, G. Gürman, T. Demirer, M. Beksac, N. Konuk, A. Uysal, H. Akan. Lessons from the activity of a single center between 1997-2002: Prof. Dr. Orhan Seyfi Şardaş hemapheresis unit experience. Blood Banking and Transfusion Medicine2003;1(Supl 1):S298 (oral presentation)
 
HE. Arslan, M. Arat, E. Soydan, H. Şenol Coşkun, P. Topçuoğlu, M Özcan, G. Gürman, T. Demirer, O. İlhan, H. Koç, M. Beksaç, N. Konuk, A. Uysal, Hakan. Does donor recipient ABO-incompatibility have any effect the course and outcome of allogeneic hematopoietic stem cell transplantation? Blood Banking and Transfusion Medicine 2003;1(Supl 1):S292 (oral presentation)
 
M. Arat, P. Topcuoglu, E.A. Soydan, G. Gürman, M. Ozcan, O. Arslan, H. Koc, O. Ilhan, N. Konuk, A. Uysal, H. Akan, M. Beksac A retrospective comparison of oral versus intravenous administration of Busulfan: Preliminary results show similar toxicity but less relapse. Bone Marrow Transplant 2003; 31 (Suppl 1): S:20 (0171) (oral presentation)
 
EA. Soydan, M. Arat, P. Topçuoğlu, Ö. Arslan, M. Özcan, D. Ergintürk, G. Gürman, O. Ilhan, M. Beksaç, H. Akan. Extra-medullary recurrence after allogeneic hematopoietic cell transplantation: a single center experience. Turkish J Haematol 2003; 20 (Suppl): 98-99
 
M. Arat, O. Arslan, E. Ayyıldız, M. Tol, O. İlhan. Performance of four different cell separators used at allogeneic hemapoietic progenitor cell collection. Blood Banking and Transfusion Medicine 2003;1(Supl 1):S356
 
M. Arat, H. Akan, E. Ayyildiz, Ö. Arslan, O. Ilhan. Comparison of vapor phase vs controlled rate freezing using HES and DMSO in three different formulations in stem cell cryopreservation (Tübitak-SBAG project no: 2189). Blood Banking and Transfusion Medicine 2003;1(Supl 1):S339
 
M. Beksac, M. Arat, K. Dalva, O. Ilhan, S.K. Toprak, G. Gurman, M. Ozcan, O. Arslan, N. Konuk, A. Uysal, H. Akan CompArative analysis of molecular response following interferon-alpha, imatinib mesilate or allogeneic stem cell transplantation (ASCT): best response is obtained with ASCT in chronic myeloid leukemia. Bone Marrow Transplant 2003; 31 (Suppl 1): S:20 (P619)
 
M. Arat, H. Akan, E. Ayyildiz, Ö. Arslan, O. Ilhan .Comparison of vapor phase vs controlled rate freezing using HES and DMSO in three different formulations for stem cell cryopreservation (TÜBITAK-SBAG Project No: 2189) Bone Marrow Transplant 2003; 31 (Suppl 1): S201 (P708)
 
O. Ilhan, S. B. Kalayoglu, A. Unal, M. Arat, O. Arslan, D. Sargin, M. Cetin, E. Ayyildiz, M. Özcan, G. Gürman, M. Beksac, H. Akan. Extracorporeal photoimmunotherapy for treatment of steroid refractory extensive chronic graft versus host disease: Turkish experience. Bone Marrow Transplant 2003; 31 (Suppl 1): S136 (P562)
 
E. Ayyildiz, M. Arat, Ö. Arslan, I. Tek, S. Gürpinar, S. Yildirim, K. Mizrak, M. Tol, O. Ilhan. Hemapheresis-related early complications during peripheral blood stem cell collections. Bone Marrow Transplant 2003; 31 (Suppl 1): S168 (P627)
 
T. Demirer, M. Ayli, O. Ilhan, H. Koc, M. Dagli, M. Arat, T. Fen, S. Dincer, G. Ozet, H. Akan, A. Uysal. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Bone Marrow Transplant 2003; 31 (Suppl 1): S195 (P695)
 
E.A. Soydan, R. Idilman, M. Arat, S. Karayalcin, C. Ustun, M. Ozcan, O. Arslan, M. Beksac, O. Ilhan, H. Akan. The effect of hepatitis B virus status of donor on the hepatitis B virus serology of recipient after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2003; 31 (Suppl 1): S:95 (P470)
 
E.A. Soydan, M. Arat, P. Topcuoglu, M. Ozcan, O. Arslan, R. Idilman, G. Gurman, M. Beksac, H. Akan, O. Ilhan The effect of mycophenolate mofetil in steroid refractory or dependent chronic graft- versus host disease. Bone Marrow Transplant 2003; 31 (Suppl 1): S135 (P561)
 
T Demirer,E Soydan,Maylı O İlhan, Mözcan M Dağlı Autologous Stem Cell Transplantation after high dose thiotepa, melphalan, carboplatin (MCB) in our lymphoma cases T.Demiere+Numune Hospital Turkish J Haematol 2003; 20 (Suppl)
 
Kutlay S,Beksaç M,Dalva K,ilhan O,Koç H,Akan H,Ozcan M. The Detection of Flow Cytometric G-CSF Receptor Expression and Its Effect on Therapy in Acute Myeloid Leukemia Leukemia & Lymphoma 44(5),791- 5,2003